Production (Stage)
Utah Medical Products, Inc.
UTMD
$53.76
$0.100.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.96M | 13.87M | 15.26M | 15.63M | 16.38M |
| Total Depreciation and Amortization | 2.88M | 2.85M | 3.16M | 4.20M | 5.29M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -110.00K | -86.00K | -558.00K | -654.00K | -651.00K |
| Change in Net Operating Assets | -1.71M | -1.80M | -630.00K | -686.00K | -371.00K |
| Cash from Operations | 14.02M | 14.83M | 17.23M | 18.49M | 20.64M |
| Capital Expenditure | -392.00K | -230.00K | -311.00K | -408.00K | -618.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 27.00K | 27.00K | 27.00K | 27.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.00K | -5.00K | -5.00K | -5.00K | -- |
| Cash from Investing | -397.00K | -208.00K | -289.00K | -386.00K | -591.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 294.00K | 390.00K | 390.00K | 426.00K | 192.00K |
| Repurchase of Common Stock | -20.20M | -19.97M | -13.26M | -9.39M | -2.99M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.19M | -4.26M | -4.29M | -4.31M | -4.30M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -24.09M | -23.84M | -17.16M | -13.28M | -7.10M |
| Foreign Exchange rate Adjustments | -12.00K | -677.00K | 468.00K | -226.00K | -56.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.48M | -9.89M | 243.00K | 4.60M | 12.90M |